Research

(iStock image)
November 8, 2024

In-clinic reconstruction of skin cancer defects costs less than OR procedures

Researchers analyzed 1,206 patient cases and found that OR reconstruction cases had a higher median baseline cost of $2,308 compared to $987 for clinic procedures.

By Kanchana Devanathan
November 8, 2024

People with schizophrenia show distinct brain activity when faced with conflicting information

Researchers introduce a biomarker to indicate whether someone is struggling with the inflexible thinking associated with the disorder.

By Joseph Caputo
November 3, 2024

Greenlight study demonstrates effective early intervention in preventing childhood obesity

Researchers examined if childhood obesity could be prevented by leveraging a combination of health behavior counseling offered by pediatric primary care clinicians and modern digital health literacy tools.

By Christina Echegaray
October 30, 2024

Genetic risk, sexual trauma associated with mental illness: study

Evaluating how genetic risk interacts with environmental risk factors such as sexual trauma is important for understanding how mental illness develops and identifying high-risk groups for early intervention.

By Leigh MacMillan
Eric Horvitz, MD, PhD
October 28, 2024

Microsoft’s Eric Horvitz set for next Discovery Lecture

Horvitz, an elected member of the National Academy of Engineering, is a pioneer in the applications of machine learning, AI and decision science.

By Bill Snyder
(iStock)
October 28, 2024

VUMC discovery aids effort to stop a deadly virus in Rwanda

A close cousin of Ebola, the Marburg virus is transmitted by fruit bats and by exposure to body fluids from infected individuals. There currently are no approved treatments or vaccines for MVD, which has a roughly 50% fatality rate.

By Bill Snyder
October 28, 2024

New research highlights economic and employment challenges for parents of medically complex babies

The study highlights that having a preterm baby often forces parents to consider leaving their job, a decision that typically involves changes to health insurance plans and networks, and resets the annual out-of-pocket costs a worker incurs.
By Holly Fletcher
October 25, 2024

Blockbuster obesity drugs also may slow kidney disease

The report supports previous clinical trials that found the GLP-1 receptor agonist drug semaglutide reduced kidney disease progression in patients with Type 2 diabetes.
By Bill Snyder
October 25, 2024

Asthma drug does not speed COVID-19 recovery: study

The study, a randomized and controlled clinical trial, tested the effectiveness of montelukast in 1,250 outpatients with acute post-COVID-19 symptoms.
By Bill Snyder and Shantell Kirkendoll
October 22, 2024

VUMC, Nigeria teaching hospital to study genetic risk of fibroids based on regional African ancestry

The research team will analyze existing genome-wide association study data and RNA sequencing to compare fibroid development patterns in Nigerian women and U.S. Black women, which could point to targeted therapies and management strategies for affected women.
By Kristin Centers
October 21, 2024

Clue to salt-sensitive blood pressure found

Despite the well-established link between high salt intake and cardiovascular disease and stroke, the mechanism of SSBP is poorly understood, and it remains an untreatable cardiovascular risk with no widely available diagnostic tool.
By Bill Snyder
October 18, 2024

All of Us tour stops at VUMC Oct. 22-25

The All of Us Research Program brings the future of health to VUMC and Nashville. 
October 16, 2024

Study of severe drug reactions finds skin cells activate their own assassins

Single-cell analysis reveals the inner workings of the life-threatening adverse drug reactions Stevens-Johnson syndrome and toxic epidermal necrolysis.
By Paul Govern
1 … 3 4 5 6 7 … 125